Daily Chart

Novartis Ag-sponsored Adr (NVS) Financial News - U.S. FDA advisory meetings through Sept. 13

Novartis Ag-sponsored Adr (NVS)

U.S. FDA advisory meetings through Sept. 13

Quote: Bisphosphonates for the treatment and prevention of osteoporosis include: FOSAMAX (alendronate sodium) tablets and solution and FOSAMAX PLUS D (alendronate sodium/cholecalciferol) tablets by Merck & Co Inc (MRK.N); ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate sodium) delayed release tablets, and ACTONEL WITH CALCIUM (Copackaged) (risedronate sodium with calcium carbonate) tablets by Warner Chilcott LLC (WCRX.O); BONIVA (ibandronate sodium) tablets and injection by Roche Therapeutics Inc (ROG.VX); RECLAST (zoledronic acid) injection by Novartis Pharmaceuticals Corp (NOVN.VX); and the generic equivalents for these products, if any. ARTHRITIS ADVISORY COMMITTEE DATE: Sept. 13, time TBD LOCATION: TBD CONTACT: Philip Bautista, 301-796-9001 The committee will discuss the anti-nerve growth factor (Anti-NGF) drug class that is currently under development and the safety issues possibly related to these drugs. The committee will be asked to determine whether reports of joint destruction represent a safety signal related to the Anti-NGF class of drugs, and whether the risk-benefit balance for these drugs favors continued development of the drugs as analgesics.(Reporting by Alina Selyukh and Anna Yukhananov; Editing by Tim Dobbyn)...
Open whole article (external link)

Other Financial and Stock Market News concerning Novartis Ag-sponsored Adr

Novartis Ag-sponsored Adr Stock Summary

Stocktweeting is not a financial advisor, and in no way recommends the purchase of any stock or advise on the suitability of any trade or investment.
Stock trading and investing can cause loss of capital, and you should always consult with a professional financial advisor before trading or investing.

This website is a service of the HagensMedia ad network. For advertising please visit http://www.hagensmedia.com - Copyright 2015.